Drreddys Laboratories | RDY - Interest Expense On Debt


Drreddys Laboratories reported INR944M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Aurora Cannabis CAD 2.11M 116K Dec/2025
Bayer EUR 675M 87M Dec/2025
Canopy Growth CAD 7.34M 1.46M Dec/2025
Cipla INR 140.3M 8.5M Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Drreddys Laboratories INR 944M 127M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Novartis USD 304M 23M Dec/2025
Pacira USD 3.89M 387K Dec/2025
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 220M 17M Dec/2025